Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 4, 1997

View Archived Issues

Chiron: Q3 1997 highlights

Sequus: Q3 1997 highlights

SangStat Medical: Q3 1997 highlights

Celgene: Q3 1997 highlights

Bausch & Lomb to acquire Chiron Vision

Promising phase III results reported for KeraVision ring

Factor Xa inhibitors prepared at DuPont Merck

NeuroSearch describes tropane derivatives that inhibit neurotransmitter reuptake

Novel class of compound enhances IFN-gamma and NT-3 activity

HMR claims dual H1/NK1 antagonists for allergic/inflammatory disorders

Bristol-Myers Squibb prepares protein farnesyltransferase inhibitors

New alpha-1-antitrypsin test launched in U.S.

Chiroscience develops new TNF/PDE IV inhibitors

Clinical trials planned for CEP-1347/KT-7515 in AD

Sequana and Glaxo Wellcome revise diabetes/obesity alliance

Oral prodrugs of novel carbapenems prepared at Wyeth-Ayerst

Preclinical results with Ergo Science's neuroendocrine resetting therapy

Phase III safety and efficacy data reported for one-alpha D2

GelTex submits NDA for RenaGel

Arris and Sequana to merge

New human rabies vaccine cleared in U.S.

Novel antihypertensive agent developed in Taiwan

Effects of riluzole on ischemia-induced glutamate accumulation in rabbits

U.S. patent issued for ABS 200 series

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...